Across TCGA pan-cancer cohorts, FRMPD4-AS1 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated FRMPD4-AS1 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher FRMPD4-AS1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated FRMPD4-AS1 expression acts as an unfavorable survival marker.

COAD, UCEC, and BRCA are the cancer types where FRMPD4-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Tertile	All	0.393	0.871	<.001	144	view →
UCEC	DFS	Tertile	II,III,IV	0.417	0.830	<.001	108	view →
BRCA	OS	Tertile	III,IV	0.140	0.833	<.001	72	view →
OV	OS	Tertile	IV	0.053	0.772	<.001	66	view →
KIRC	DFS	Tertile	IV	0.127	0.619	.008	54	view →
STAD	OS	Tertile	All	0.268	0.739	<.001	45	view →
BLCA	DFS	Tertile	All	0.159	0.625	.016	45	view →
PCPG	OS	Tertile	All	0.524	0.975	<.001	27	view →
UCS	OS	Tertile	All	0.185	0.686	.034	18	view →
LIHC	OS	Tertile	All	0.156	0.783	.002	18	view →
THYM	OS	Tertile	All	0.700	0.973	.020	6	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

Exploration

Same gene, other analysis: FRMPD4-AS1 tumor-vs-normal RNA expression · all FRMPD4-AS1 data types